1.54 USD
+0.13 (+9.22%)
At close: Feb 6, 2026
1.52 USD
-0.02 (-1.3%)
After Hours: 2/6/2026, 8:00:01 PM
ChartMill assigns a Buy % Consensus number of 80% to MGX. The Buy consensus is the weighted average rating of the current analysts ratings.
- Analysts have set a mean price target forecast of 9.52. This target is 518.18% above the current price.
- MGX was analyzed by 9 analysts. The buy percentage consensus is at 80. So analysts seem to be have mildly positive about MGX.
- In the previous month the buy percentage consensus was at a similar level.
- MGX was analyzed by 9 analysts. More opinions would make the average more meaningful.
Price Target & Forecast
| Date | Firm | Action | Rating |
|---|---|---|---|
| 2025-08-19 | HC Wainwright & Co. | Reiterate | Buy -> Buy |
| 2025-08-15 | Chardan Capital | Maintains | Buy -> Buy |
| 2025-08-14 | Wells Fargo | Maintains | Overweight -> Overweight |
| 2025-05-15 | Chardan Capital | Maintains | Buy -> Buy |
| 2025-05-14 | Wells Fargo | Maintains | Overweight -> Overweight |
| 2025-04-03 | HC Wainwright & Co. | Maintains | Buy -> Buy |
| 2025-03-18 | Wells Fargo | Maintains | Overweight -> Overweight |
| 2024-12-10 | HC Wainwright & Co. | Maintains | Buy -> Buy |
| 2024-11-21 | HC Wainwright & Co. | Reiterate | Buy -> Buy |
| 2024-11-20 | Chardan Capital | Maintains | Buy -> Buy |
| 2024-10-15 | HC Wainwright & Co. | Reiterate | Buy -> Buy |
| 2024-09-06 | HC Wainwright & Co. | Reiterate | Buy -> Buy |
| 2024-09-05 | Chardan Capital | Maintains | Buy -> Buy |
| 2024-08-21 | HC Wainwright & Co. | Maintains | Buy -> Buy |
| 2024-08-19 | Chardan Capital | Maintains | Buy -> Buy |
| 2024-08-15 | BMO Capital | Maintains | Outperform -> Outperform |
| 2024-07-15 | HC Wainwright & Co. | Reiterate | Buy -> Buy |
| 2024-05-15 | HC Wainwright & Co. | Reiterate | Buy -> Buy |
| 2024-05-07 | HC Wainwright & Co. | Initiate | Buy |
| 2024-05-02 | JP Morgan | Downgrade | Overweight -> Neutral |
| 2024-03-28 | Chardan Capital | Maintains | Buy -> Buy |
| 2024-03-05 | TD Cowen | Initiate | Outperform |
| 2024-03-05 | Chardan Capital | Initiate | Buy |
| 2024-03-05 | BMO Capital | Initiate | Outperform |
| 2024-03-05 | Wells Fargo | Initiate | Overweight |
| 2024-03-05 | JP Morgan | Initiate | Overweight |
| 2024-03-05 | Jefferies | Initiate | Buy |
METAGENOMI THERAPEUTICS INC / MGX FAQ
What do analysts expect the price target to be for METAGENOMI THERAPEUTICS INC (MGX)?
9 analysts have analysed MGX and the average price target is 9.52 USD. This implies a price increase of 518.18% is expected in the next year compared to the current price of 1.54.
What is the consensus rating for MGX stock?
The consensus rating for METAGENOMI THERAPEUTICS INC (MGX) is 80 / 100 . This indicates that analysts generally have a positive outlook on the stock.
How many analysts have analysed METAGENOMI THERAPEUTICS INC (MGX)?
The number of analysts covering METAGENOMI THERAPEUTICS INC (MGX) is 9.